MTNB - Matinas BioPharma Holdings, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5115.82M
Enterprise Value 393.05M
Trailing P/E N/A
Forward P/E 1-5.40
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1,289.60
Price/Book (mrq)3.48
Enterprise Value/Revenue 31,036.01
Enterprise Value/EBITDA 6-6.47

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-16,288.19%

Management Effectiveness

Return on Assets (ttm)-29.46%
Return on Equity (ttm)-54.53%

Income Statement

Revenue (ttm)89.81k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-6.67M
EBITDA -14.37M
Net Income Avi to Common (ttm)-15.05M
Diluted EPS (ttm)-0.1450
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)39.41M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)4.65M
Total Debt/Equity (mrq)10.80
Current Ratio (mrq)12.81
Book Value Per Share (mrq)0.23

Cash Flow Statement

Operating Cash Flow (ttm)-10.54M
Levered Free Cash Flow (ttm)-4.56M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.13
52-Week Change 383.56%
S&P500 52-Week Change 38.59%
52 Week High 31.5000
52 Week Low 30.3240
50-Day Moving Average 30.9217
200-Day Moving Average 30.9824

Share Statistics

Avg Vol (3 month) 3841.02k
Avg Vol (10 day) 3554.63k
Shares Outstanding 5142.99M
Float 115.14M
% Held by Insiders 110.40%
% Held by Institutions 113.41%
Shares Short (May 31, 2019) 45.13M
Short Ratio (May 31, 2019) 45.2
Short % of Float (May 31, 2019) 45.31%
Short % of Shares Outstanding (May 31, 2019) 43.59%
Shares Short (prior month Apr 30, 2019) 44.61M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A